Adverse events considered not related to treatment were: grade 3 asthenia and grade 3 hyperglycaemia in 1 patient; grade 2 AEs in 13 patients [asthenia (n = 4), pain (n = 4), infection (n = 4), headache (n = 3), balance disorder (n = 3), constipation (n = 2), insomnia (n = 2), anorexia (n = 1), hyperglycaemia (n = 1), hyponatremia (n = 1), paraesthesia (n = 1), cutaneous/mucus disorder (n = 1), liver disorder (n = 1), ocular disorder (n = 1), epigastralgia (n = 1)].
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